Navigation Links
MCG receives $100,000 Grand Challenges Explorations grant for innovative global health research
Date:11/5/2008

AUGUSTA, Ga. The Medical College of Georgia announced today that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Dr. Pandelakis A. Koni titled "Antibody-Dependent Cellular Cytotoxicity Targeted Against HIV-1 Env Glycans."

Dr. Koni's project is one of 104 grants recently announced by the Gates Foundation for the first funding round of Grand Challenges Explorations, an initiative to help scientists around the world explore bold, new solutions for health challenges in developing countries. The grants were provided to all levels of scientists in 22 countries and five continents.

To receive funding, Dr. Koni showed in a two-page application how his idea falls outside current scientific paradigms and could lead to significant advances in global health if successful.

His goal is to develop a vaccine against HIV, a virus that is notoriously slippery, constantly mutating itself to avoid being targeted by the immune system. In fact, the dynamic of this virus is one reason vaccines to date have failed, Dr. Koni said. But he thinks there may be chinks in the armor. Like many cells in the body, HIV and HIV-infected cells are sugar-coated. In fact, one role of this complex carbohydrate shield is believed to be protecting HIV from attack. However there are some consistencies in the sugar coating which Dr. Koni believes are critical to the virus and may be good vaccine targets.

As a first step, the immunologist is working to develop antibodies to these segments of the sugar coating with the idea that they are sites of potential vulnerability for the durable virus. "My idea is that these areas are always conserved and are consistent for a reason," said Dr. Koni. While his goal is to develop a protective vaccine, Dr. Koni said if he's successful in his pursuit, the antibodies may provide new targeted treatment strategies as well.

"I congratulate each individual who took the initiative to share their idea with us to help fight the world's most serious diseases," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "The number of creative approaches we received exceeded our highest aspirations. Projects from this initial pool of grants have the potential to transform health in developing countries, and I will be rooting for their success."


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

Related medicine news :

1. LifeMasters Receives Full Accreditation for Disease Management Programs
2. SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER
3. WorldHeart Receives Notice From the NASDAQ Stock Market Regarding Non-Compliance With Marketplace Rule 4310(c)(7)
4. Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
5. New Skin Rejuvenation Discovery Receives Commercial Backing
6. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
7. LifeNet Health Receives FDA Clearance for New Cardiovascular Technology
8. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Weill Cornell Medical College receives 2 $100,000 grants for innovative global health research
11. HealthWorldNet.com Receives Three Excellence Awards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MCG receives $100,000 Grand Challenges Explorations grant for innovative global health research
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: